Surgical Treatment of Obesity. Special Mention to Roux-en-Y Gastric Bypass and Vertical Gastrectomy

Luesma, María José; Fernando, José; Cantarero, Irene; Lucea, Pilar; Santander, Sonia

doi:10.3389/fendo.2022.867838

Cited by 15 publications

(19 citation statements)

References 91 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The mean age of the participants was 32.81 years; this was in accordance with the other study in Saudi Arabia when the mean age was 33.3 years(Alfadda et al, 2021), while it was younger than in the study in Norway(Järvholm et al, 2021). The age range in the current study was from 15 to 62 year, it was aligned with the internationally recommended age range for bariatric surgery of 18 to 65 years old(Luesma et al, 2022). According to our study, 16.1% of participants suffered from GERD following bariatric surgery, 32.7% were diagnosed with GERD before bariatric surgery and 51.2% of bariatric surgery patients were not diagnosed with GERD.…”

supporting

confidence: 89%

See 1 more Smart Citation

The association between gastro esophageal reflux disease and bariatric surgery

Alrashid¹,

Alsanea²,

Alrasheed³

et al. 2022

View full text Add to dashboard Cite

Background: Obesity is ordinarily accompanying gastro esophageal reflux disease. Thus, losing weight will improve it. In contrary it can occur after bariatric surgery as a complication and in some cases, it may appear and develop for the first time as consequence of bariatric surgery. Aims: To determine the association between gastro esophageal reflux disease and bariatric surgery among patients underwent bariatric surgery in Hail region, Saudi Arabia. Methodology: From February to June 2022, a cross sectional study included all patients who underwent bariatric surgery in Hail region. The extracted data had been manipulated statistically using IBM SPSS version 22.0. Results: Out of 477 patients that managed by the mean of bariatric surgery, 379 participants were responded effectively to the study survey. In consideration of demographics, 41.7% of the participants were aged 15-30 years. Most of them (55.9%) were male. Before surgery, 32.7% had gastro esophageal reflux disease and 60.5% of them had shown improvement after surgery. Post surgical procedure, 16.1% of the participants had a newly developed gastro esophageal reflux disease. Nearly, 67.3% of the participants had a laparoscopic sleeve gastrectomy and 48.8% were diagnosed with gastro esophageal reflux disease. Statistics indicate that bariatric surgery and gastro esophageal reflux disease are significantly correlated (P=0.000). Conclusion: Each patient should be made aware of the risks of gastro esophageal reflux disease accompanying such procedures.

show abstract

supporting

confidence: 89%

“…A former Saudi Arabian study found an opposite finding, as there was no statistically noteworthy association with age, gender and diabetes as a chronic disease (p > 0.05), but it showed significant association with smoking (P=0.02) (Luesma et al, 2022).…”

Section: Discussionmentioning

confidence: 87%

The association between gastro esophageal reflux disease and bariatric surgery

Alrashid¹,

Alsanea²,

Alrasheed³

et al. 2022

View full text Add to dashboard Cite

show abstract

“…On the other hand, the hazard ratio for suicide was 2.4 times higher with surgery compared with non-surgery participants (95% CI: 1.57–3.68; p < 0.001), primarily in participants aged 18–34 years at surgery [ 79 ]. When choosing the most appropriate surgical technique, different factors must be taken into account, such as the primary aim of the treatment, the individual CV risk, the eventual digestive or esophago-gastric pathology, and the patient’s preference [ 81 ]. BS techniques can be classified as restrictive, malabsorptive, and mixed, based on the mechanism of action, as well as endoscopic or laparoscopic, based on the approach ( Table 3 ).…”

Section: Surgical Managementmentioning

confidence: 99%

“…Specifically, the laparoscopic vertical SG is a restrictive procedure that changes the gastric emptying, removing the fundus gastric, and dramatically reducing the production of ghrelin, having an additional anorectic action. On the contrary, RYGB is a mixed procedure: both restrictive, due to the small gastric pouch, and malabsorptive of sugars and fats, due to the bypass of the pancreatic duodenum that carries partially digested food to the distal intestine, thus improving glycemic balance [ 81 ]. A recently published meta-analysis in 114,919 patients did not find a clear effect of sex difference on the efficacy outcome of BS procedures, but men were more likely to achieve greater BMI loss, while women were 2.87 times more likely to be classified as weight responders (95% CI 1.90–4.34), with a higher percentage of excess weight loss, in particular after an intragastric balloon (0.72 95% CI: 0.42–1.02) [ 83 ].…”

Section: Surgical Managementmentioning

confidence: 99%

Obesity and Cardiovascular Risk: Systematic Intervention Is the Key for Prevention

Perone¹,

Pingitore

Conte³

et al. 2023

Healthcare

View full text Add to dashboard Cite

Obesity is a serious public health issue and associated with an increased risk of cardiovascular disease events and mortality. The risk of cardiovascular complications is directly related to excess body fat mass and ectopic fat deposition, but also other obesity-related complications such as pre-type 2 diabetes, obstructive sleep apnoea, and non-alcoholic fatty liver diseases. Body mass index and waist circumference are used to classify a patient as overweight or obese and to stratify cardiovascular risk. Physical activity and diet, despite being key points in preventing adverse events and reducing cardiovascular risk, are not always successful strategies. Pharmacological treatments for weight reduction are promising strategies, but are restricted by possible safety issues and cost. Nonetheless, these treatments are associated with improvements in cardiovascular risk factors, and studies are ongoing to better evaluate cardiovascular outcomes. Bariatric surgery is effective in reducing the incidence of death and cardiovascular events such as myocardial infarction and stroke. Cardiac rehabilitation programs in obese patients improve cardiovascular disease risk factors, quality of life, and exercise capacity. The aim of this review was to critically analyze the current role and future aspects of lifestyle changes, medical and surgical treatments, and cardiac rehabilitation in obese patients, to reduce cardiovascular disease risk and mortality, and to highlight the need for a multidisciplinary approach to improving cardiovascular outcomes.

show abstract

“…It represents the second most performed procedure [ 1 , 2 ]. This popularity is due to consistently satisfying and long-lasting weight loss and comorbidity resolution with acceptable complications and mortality rates [ 3 ]. Most patients expect to lose more than 70% of their excess weight in the first 12 months after the surgery.…”

Section: Introductionmentioning

confidence: 99%

Predictors for weight loss after Roux-en-Y gastric bypass: the trend and associated factors for weight loss

et al. 2022

View full text Add to dashboard Cite

Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. Methods This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m2 or BMI > 35 kg/m2 along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12–60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. Results The mean ± SD age, weight, and BMI at surgery were 40.1 ± 10.58 years, 123.32 ± 19.88 kg, and 45.78 ± 5.54 kg/m2, respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m2) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). Conclusions BS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS.

show abstract

Surgical Treatment of Obesity. Special Mention to Roux-en-Y Gastric Bypass and Vertical Gastrectomy

Cited by 15 publications

References 91 publications

The association between gastro esophageal reflux disease and bariatric surgery

The association between gastro esophageal reflux disease and bariatric surgery

Obesity and Cardiovascular Risk: Systematic Intervention Is the Key for Prevention

Predictors for weight loss after Roux-en-Y gastric bypass: the trend and associated factors for weight loss

Contact Info

Product

Resources

About